Tiny stem cell firms close in on major heart disease goals

Business Dec 19, 2017

Tiny stem cell firms close in on major heart disease goals

The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp. abandoning the field in 2011. But two small companies, Athersys ...

Editorials Sep 7, 2017

Unauthorized cord blood treatments

The recent arrests over alleged unauthorized stem cell therapies using blood collected from umbilical cords and placentas has shed light on the shady aspects of these expensive treatments.